Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists
- 1 September 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (18) , 5063-5065
- https://doi.org/10.1016/j.bmcl.2008.07.123
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interfering with chemokines and chemokine receptors as potential new therapeutic strategiesExpert Opinion on Therapeutic Patents, 2008
- Monocyte chemoattractant protein-1 and atherosclerosis: Is there room for an additional biomarker?Clinica Chimica Acta; International Journal of Clinical Chemistry, 2007
- Chemokine:Receptor Structure, Interactions, and AntagonismAnnual Review of Immunology, 2007
- ChemokinesThe Scientific World Journal, 2007
- Chemokine inhibition in inflammatory arthritisBest Practice & Research Clinical Rheumatology, 2006
- The Many Roles of Chemokines and Chemokine Receptors in InflammationNew England Journal of Medicine, 2006
- The CCR2 receptor as a therapeutic targetExpert Opinion on Therapeutic Patents, 2005
- The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)Seminars in Immunology, 2003
- Monocyte Chemoattractant Protein-1 (CCL2) in Inflammatory Disease and Adaptive Immunity: Therapeutic Opportunities and ControversiesMicrocirculation, 2003
- Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout miceCurrent Opinion in Lipidology, 2001